You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

NORPLANT SYSTEM IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Norplant System In Plastic Container patents expire, and what generic alternatives are available?

Norplant System In Plastic Container is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in NORPLANT SYSTEM IN PLASTIC CONTAINER is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Norplant System In Plastic Container

A generic version of NORPLANT SYSTEM IN PLASTIC CONTAINER was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORPLANT SYSTEM IN PLASTIC CONTAINER?
  • What are the global sales for NORPLANT SYSTEM IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for NORPLANT SYSTEM IN PLASTIC CONTAINER?
Drug patent expirations by year for NORPLANT SYSTEM IN PLASTIC CONTAINER
Recent Clinical Trials for NORPLANT SYSTEM IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Women and Infants Hospital of Rhode IslandN/A
Oregon Health and Science UniversityPhase 4
Society of Family PlanningPhase 4

See all NORPLANT SYSTEM IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for NORPLANT SYSTEM IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc NORPLANT SYSTEM IN PLASTIC CONTAINER levonorgestrel IMPLANT;IMPLANTATION 020088-001 Dec 10, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NORPLANT SYSTEM IN PLASTIC CONTAINER

See the table below for patents covering NORPLANT SYSTEM IN PLASTIC CONTAINER around the world.

Country Patent Number Title Estimated Expiration
France 1397506 Procédé de préparation de nouveaux composés tétracycliques ⤷  Sign Up
Austria 264728 ⤷  Sign Up
Italy 1061051 PROCEDIMENTO PER RPEPARARE INTERMEDI DI STEROIDI ⤷  Sign Up
United Kingdom 1010053 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for NORPLANT SYSTEM IN PLASTIC CONTAINER

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1453521 CA 2016 00016 Denmark ⤷  Sign Up PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
1453521 C201630040 Spain ⤷  Sign Up PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211
1453521 39/2015 Austria ⤷  Sign Up PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
1453521 15C0050 France ⤷  Sign Up PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.